Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | genetic association 0.13 (overall 0.08) | 0.13 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | no papers tie it to Parkinson's yet | 1.00 |
| pathways Reactome | 1 pathway; mostly mitochondrial quality control | 1.00 |
No case: the score is under the bar. Receipt 3336
Sealed predictions
- CMC1 in dopamine neurons, braak+0.21 (p 0.586) → +0.76 (p 0.019)receipt 3344
Swarm cases
receipt 3344: CMC1 in dopamine neurons, braak
- power
- full sample +0.38 (p 0.120, n 18), 95% CI -0.11 to +0.72. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.43 (p 0.075, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.46 (p 0.054, n 18). could be the mix.
- skeptic
- leave-one-out range +0.29 to +0.58, sign flips 0; without severely affected donors +0.38 (p 0.120, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for CMC1 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts